Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarboxamides

D. Bonafoux(Pfizer (United States)), Sumathy Mathialagan(Pfizer (United States)), Sheri L. Bonar(Washington University in St. Louis), Cindy Sommers(Pfizer (United States)), William E. McGhee(Pfizer (United States)), Julia A. Guzova(Pfizer (United States)), Sharon Rouw(Pfizer (United States)), Michael B. Tollefson(Pfizer (United States)), Adam H. Libby(Pfizer (United States)), Richard M. Weier(Pfizer (United States)), Michael Clare(National Oceanography Centre), Catherine S. Tripp(Pfizer (United States)), Patrick J. Lennon(Pfizer (United States)), Nandini Kishore(Pfizer (United States)), Lori J. Christine(Pfizer (United States)), Serge G. Wolfson(Pfizer (United States)), Ann M. Donnelly(Pfizer (United States))
Bioorganic & Medicinal Chemistry Letters
April 20, 2005
Cited by 30


Related Papers